FILANA THERAPEUTICS, INC.
FLNA · Pharmaceutical Preparations · 48.3M shares · +4%/yr ↑ dilution · EDGAR filings ↗
Reference price $2.90 · est. market cap ~$140M — last insider purchase, 2025-11-24 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D42Clinical/early-stage biotech — deep losses
Strengths
- Liquidity — current ratio 2.2 (29th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical/pipeline & funding risk — per 10-K
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Cash burnNegative free cash flow (-32.8M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Notable holderHeld by 5 notable fund(s): RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, STATE STREET CORP +2 more (as of 2026-03-31)
- New fund positionNotable fund(s) opened this quarter: RENAISSANCE TECHNOLOGIES LLC
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
-122.3%
Return on assets
-76.9%
Current ratio
2.2×
Free cash flow
-$33M
Tangible book value
$74M
Cash & investments
$96M
Cash runway
12q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2025-11-24 | Anderson Robert Eugene Jr | Buy | 8.6K | $2.90 |
| 2025-11-20 | Barry Richard | Buy | 150K | $2.76 |
| 2025-11-19 | Barry Richard | Buy | 73K | $2.75 |
| 2025-09-30 | Cook Robert Christopher | Buy | 14K | $2.91 |
| 2025-09-22 | Barry Richard | Buy | 7.2K | $2.28 |
| 2025-09-19 | Barry Richard | Buy | 400 | $2.25 |
| 2025-09-19 | Barry Richard | Buy | 47K | $2.29 |
| 2025-09-18 | Barry Richard | Buy | 5.4K | $2.13 |
| 2025-09-18 | Barry Richard | Buy | 185K | $2.24 |
All non-derivative Form 4 activity (SEC), newest first.
Supply chain
Customers (0)
Suppliers (2)
- Evonik Corporation
- Yale University
Named in the 10-K; linked when we track them.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-15 | Exec/director changeShareholder voteExhibits | filing ↗ |
| 2026-05-07 | ResultsExhibits | filing ↗ |
| 2026-04-28 | Exec/director change | filing ↗ |
| 2026-03-12 | ResultsExhibits | filing ↗ |
| 2026-03-10 | 5.03Reg FDExhibits | filing ↗ |
| 2026-02-19 | Reg FDOtherExhibits | filing ↗ |
| 2025-12-23 | Material agreement | filing ↗ |
| 2025-12-22 | Exec/director changeExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-15 | 2026-06-11 | 0001437749-26-020562 ↗ |
| 10-Q | 2026-05-07 | 2026-03-31 | 0001437749-26-015664 ↗ |
| 8-K | 2026-05-07 | 2026-05-07 | 0001171843-26-003119 ↗ |
| 8-K | 2026-04-28 | 2026-04-22 | 0001437749-26-013638 ↗ |
| 10-K | 2026-03-12 | 2025-12-31 | 0001437749-26-007962 ↗ |
| 8-K | 2026-03-12 | 2026-03-12 | 0001171843-26-001506 ↗ |
| 8-K | 2026-03-10 | 2026-03-10 | 0001437749-26-007422 ↗ |
| 8-K | 2026-02-19 | 2026-02-19 | 0001171843-26-000922 ↗ |
| 8-K | 2025-12-23 | 2025-12-19 | 0001437749-25-038605 ↗ |
| 8-K/A | 2025-12-22 | 2025-10-21 | 0001437749-25-038544 ↗ |
| 8-K | 2025-12-18 | 2025-12-15 | 0001437749-25-038313 ↗ |
| 8-K | 2025-12-17 | 2025-12-12 | 0001437749-25-038157 ↗ |